With 60,000+ members, SheMed raises €43 million to advance personalised women’s healthcare in the UK
SheMed, London’s female-founded HealthTech company changing how women access personalised healthcare, today announced it has raised €43 million to further develop its innovative health platform and advance new breakthroughs for preemptive healthcare. The new funding will be used to expand SheMed’s UK operations, scaling its medical and technology teams, strengthening clinical infrastructure and enhancing its […]
GLP-1 Medicines From Metabolic Agents to Multi System Therapeutics
GLP-1 Medicines From Metabolic Agents to Multi System Therapeutics
Blood Thinners & Anti-Obesity Shots Dominate Medicare Drug Spending
Blood Thinners & Anti-Obesity Shots Dominate Medicare Drug Spending From diabetes injectables to blockbuster blood thinners, a handful of drugs account for a sizable share of Medicare’s pharmacy bill. This visualization, via Visual Capitalist’s Pallavi Rao, ranks the most common drugs by total Medicare spending in 2023, sourced from Centers for Medicare & Medicaid Services It tracks every […]
A MARKETING BOON FOR GLP-1 DRUGS: “Astounding” – 70% of Americans Have Obesity by New, More A
A MARKETING BOON FOR GLP-1 DRUGS: “Astounding” – 70% of Americans Have Obesity by New, More Accurate Definition. Weirdly, more people need blood pressure drugs under the new high blood pressure definition, and more people need diabetes drugs under the new blood sugar guidelines.
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S on The Analyst’s Journal’s Substack by A_Capital. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S’s share was trading at $56.72 as of October 15th. NVO’s trailing and forward P/E were 14.98 and 14.08, respectively according to Yahoo Finance. Novo Nordisk A/S represents a compelling long-term growth […]
The Stupidest Thing in American Health Care? Failing to Tackle Obesity Early.
It takes a very particular kind of political brainworm to look at a country where nearly half the population is obese, where Medicare and Medicaid hemorrhage cash treating diabetes, heart disease, stroke, and cancer — and say: let’s not pay for the medicine that actually fixes the root problem. And yet, here we are. GLP-1 […]
Semaglutide helps heart regardless of how much weight lost, study reveals
Anti-obesity medication semaglutide may help to prevent heart attacks and other major cardiac events regardless of how much weight people lose while taking the drug, according to a new study led by a UCL researcher.
SCIENCE: Study finds GLP-1 drugs may help prevent risks from sleep apnea.
SCIENCE: Study finds GLP-1 drugs may help prevent risks from sleep apnea.
GLP-1 Medications, Like Ozempic, May Help To Slow Or Even Reverse Aging According To New Study
Shutterstock GLP-1 drugs such as Ozempic have been shown to be extremely effective at helping diabetics manage their blood sugar, and almost anyone else to lose weight and keep it off. These drugs have also been shown to help stop addictions of all types in many people. A new study performed by TruDiagnostic has one […]
Why Everything From Perfume to Soap Smells Like Food Now
As demand for products scented like vanilla, pistachio and other edible indulgences soars, some GLP-1 users say there’s a link to their changed eating habits.